""IT'S CLEAR THIS TREATMENT IS WORKING WELL""29 Sep 2025 07:01
""IT'S CLEAR AS DAY THIS TREATMENT IS WORKING WELL""
HEMO'S CLINICAL TRIAL TREATMENT HAVE SUCCESSFULLY TREATED 3 PATIENTS ( IMPORTANTLY 3RD PATIENT AML CELLS WERE NOT DETECTABLE THIS IS A MASSIVE BREAKTHROUGH )
& 4TH PATIENT UPDATE WILL BE VERY SOON
HEMO HAVE BEEN GIVEN THE GREEN LIGHT TO START TREATING CHILDREN THAT ARE REALLY SICK.
THE PAST FEW RNS'S SHOW CLEAR PROGRESS
RNS dated 23rd Sept 25: Hemogenyx Pharmaceuticals Signs Letter of Intent with Cellin Technologies to Advance Commercialization of HG-CT-1 CAR-T Therapy in Estonia. First of many Potential Near-Term Revenue Opportunity's to come
RNS dated 18th Sept 25: TR-1: Standard form for notification of major holdings shows and tells you buyers are loading up.
RNS dated 17th Sept 25:: The third patient has been successfully treated. The treatment was well tolerated and met the trial's predefined initial safety criteria. IMPORTANTLY, early indications of clinical efficacy have been observed. Preliminary assessment shows that original AML CELLS WERE NOT DETECTABLE in the patient using standard testing methods. THIS IS A MASSIVE BREAKTHROUGH
""The treatment was well tolerated and met the trial's predefined initial safety criteria. Importantly, early indications of clinical efficacy have been observed. Preliminary assessment shows that original AML cells were "not detectable" in the patient using standard testing methods.
RNS dated 11th Sept 25: "We are honored to have been invited to present Hemogenyx at the DCNY Summit. This prestigious event convenes a remarkable group of global investors, corporate leaders, and policymakers, and provides us with a unique opportunity to highlight our progress and to engage with those who can help accelerate our mission to transform the treatment of cancer." This has to be a massive hint things are going really well, if "your invited" to be where the money 💰 is. So hemo is now not looking for money but the other way round now "the money is looking for Hemogenyx "
RNS dated 8th Sept 25::"Partnering with a trusted CDMO like Made Scientific is essential to the success of HG-CT-1, our lead CAR-T therapy. Made's expertise in cell therapy manufacturing will be instrumental in driving the continued progress of this potentially breakthrough therapy for patients with relapsed or refractory AML, fully in line with our identity as a life saving company." Perfect partners for the perfect road map going forward at full speed ahead captain
RNS dated 15th Aug 25: ""The Company is pleased to report that the first two patients treated with HG-CT-1 remain alive at six months and three months post-treatment, respectively. "" which means now patient one is alive at over 7 months and patient two is alive over 4 months now come on this is great news 👍 everyone has to agree.
""IT'S CLEAR THIS TREATMENT IS WORKING WELL""
Sign In
Follow the stocks
